Compounds > phenylalanyl-glycyl-leucyl-methioninamide

phenylalanyl-glycyl-leucyl-methioninamide and Cranial-Nerve-Diseases

phenylalanyl-glycyl-leucyl-methioninamide has been researched along with Cranial-Nerve-Diseases* in 1 studies

Other Studies

1 other study(ies) available for phenylalanyl-glycyl-leucyl-methioninamide and Cranial-Nerve-Diseases

ArticleYear
Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I.
    Lancet (London, England), 1998, Jun-13, Volume: 351, Issue:9118

    Topics: Corneal Diseases; Cranial Nerve Diseases; Drug Therapy, Combination; Epithelium, Corneal; Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Oligopeptides; Paralysis; Trigeminal Nerve; Visual Acuity; Wound Healing

1998